Option Care Health, Inc. (NASDAQ:OPCH) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have been given a consensus rating of “Moderate Buy” by the six brokerages that are currently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $30.83.

A number of analysts have commented on OPCH shares. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Truist Financial decreased their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. Barrington Research decreased their price objective on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. JMP Securities boosted their target price on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th. Finally, The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and cut their target price for the stock from $38.00 to $27.00 in a research note on Monday, November 4th.

Option Care Health Stock Performance

Shares of OPCH opened at $23.59 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a 50 day moving average price of $26.53 and a two-hundred day moving average price of $28.79. The firm has a market capitalization of $4.01 billion, a P/E ratio of 19.82, a P/E/G ratio of 2.50 and a beta of 1.33. Option Care Health has a 52 week low of $21.39 and a 52 week high of $34.63.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the purchase, the director now owns 326,334 shares in the company, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.64% of the stock is owned by company insiders.

Hedge Funds Weigh In On Option Care Health

Several institutional investors have recently bought and sold shares of OPCH. Janus Henderson Group PLC lifted its stake in Option Care Health by 182.9% in the first quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock valued at $7,617,000 after purchasing an additional 146,837 shares during the last quarter. Tidal Investments LLC lifted its position in shares of Option Care Health by 74.2% during the first quarter. Tidal Investments LLC now owns 13,460 shares of the company’s stock worth $451,000 after acquiring an additional 5,733 shares in the last quarter. Harbor Capital Advisors Inc. lifted its position in shares of Option Care Health by 317.9% during the second quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock worth $2,670,000 after acquiring an additional 73,312 shares in the last quarter. SG Americas Securities LLC lifted its position in shares of Option Care Health by 619.3% during the second quarter. SG Americas Securities LLC now owns 60,356 shares of the company’s stock worth $1,672,000 after acquiring an additional 51,965 shares in the last quarter. Finally, Blue Trust Inc. lifted its position in shares of Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after acquiring an additional 377 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.